The 3rd China Traditional Chinese Medicine Expo, three days of trade turnover of more than 3 billion yuan

Business Agency, May 27 - May 23-25, the 3rd China (Yulin) Chinese Medicine Expo (hereafter referred to as the Pharmaceutical Expo) was held in Yulin Yinfeng International Chinese Medicine Port in GuangxiThe State Administration of Traditional Chinese Medicine, the relevant leaders of Guangxi local government departments, as well as pharmaceutical enterprises, medical institutions and Chinese and foreign investors, buyers, and city delegations from all over the country attended by about 5,000 peopleThe three-day drug fair trade turnover reached 3.02 billion yuan, an increase of 11.9% over the previous session, and the contract turnover reached 3.83 billion yuan, an increase of 79.8% over the previous sessionIn 2011, Guangxi medical institutionsthe purchase and sale of drugscontract signed will reach the purchase amount of 8,007 million yuanThePharmaceutical Expo will continue to take the theme of "health, development, cooperation and win-win situation" as the theme, to "promote the chinesemedicineculture, develop the Chinese medicine industry, expand the southern medicine capital" for the purpose, to "government guidance, enterprise participation" as the operating mechanism, to build a Chinese medicine as the medium ofinvestmentinvestment platform, focus on the pharmaceutical fair will be a wide-ranging influence at home and abroad, the promotion of chinese medicine trade, cultural exchangeAccording to the organizers, the third pharmaceutical fair in the original 1000 fixed dealers on the basis of the exhibition, the addition of 300 international standard booths, attracted from 28 provinces (municipalities, autonomous regions), Hong Kong and Taiwan regions as well as ASEAN, the United States and other regions a total of 316enterprisesexhibit2011, China (Yulin) Southern Pharmaceutical (Pharmaceutical) Import and Export Trade Summit and Bulk Medicines (Pharmaceuticals) Trading Signing Ceremony, Guangxi Medical Institutions Drug Purchase and Sale Contract Signing Conference, Yulin City 100 Billion Chinese Medicine Industry Development Planning Press Conference, Yulin Health Industry Park Investment Promotion and other large-scale project publicity and promotion, project docking negotiations, project signing ceremony activities are also held during the Drug ExpoAmong them, in 2011, Guangxi medical institutions drug purchase and sale contract signed will also organize more than 380 medical institutions in the region, more than 60 large pharmaceutical enterprises at home and abroad and more than 300 drug distribution centers, held drug purchase and sale contract signing activities, the number of participants reached more than 3000 people 　　By the exhibition to promote the brand
the current drug fair is mainly divided into Chinese medicine drink film exhibition, ethnic minority characteristics of the pharmaceutical exhibition, ASEAN Hong Kong, Macao and Taiwan pharmaceutical exhibition, health care products exhibition and native medicinal products exhibition 5 exhibition areas in addition to the industry, there are still many people to visit and buy Chinese medicine products Zhang Jian, regional manager of Chongqing Yandu Pharmaceutical Co., Ltd., told reporters that although the exhibition site transactions are still mainly retail-based, but can use the drug fair this platform for brand promotion, improve corporate visibility the drug fair is divided into three major sectors, such as economy, trade, academia and culture In addition to the most concerned economic and trade sectors, the content of the academic sector for the development and development of the Chinese medicine industry is also very rich Southern Pharmaceutical Forum - Chinese Medicine Zhuang Zhuang Pharmaceutical Industry Development Forum invited domestic famous experts and scholars and entrepreneurs, with "Chinese medicine Zhuang Zhuang pharmaceutical industry development" as the theme, to explore the new situation of chinese medicine industry, especially the development of the national pharmaceutical industry, path selection and how to do better and stronger through scientific and technological innovation and other issues; (Reporter Liu Hong trainee reporter Ou Huimin)